Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_assertion type Assertion NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_head.
- NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_assertion description "[The resulting tumor-selective radionuclide accumulation was high enough for a therapeutic effect of (131)I and (188)Re opening the exciting prospect of NIS-mediated radionuclide therapy of metastatic cancer using genetically engineered MSCs as gene delivery vehicles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_provenance.
- NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_assertion evidence source_evidence_literature NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_provenance.
- NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_assertion SIO_000772 23402366 NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_provenance.
- NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_assertion wasDerivedFrom befree-20150227 NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_provenance.
- NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_assertion wasGeneratedBy ECO_0000203 NP697603.RA-34WAZct4mhLbRslfOmX7F30ZNROjBLVRgQYHke-VmU130_provenance.